Skip to main content

Start-up Pharmacogenomics Firm Gentris Locks in $1.5M in Private Equity

NEW YORK, March 19 - Start-up pharmacogenomics company Gentris on Tuesday said it has secured $1.5 million in private-equity financing.

 

Research Triangle Ventures and Exelixis led the round, which also included angel investors.

 

Gentris said it plans to use the cash to "up-fit" its lab and hire "key senior staff."

 

The company, founded last year, aims to build a "turnkey pharmacogenomic solution of products and services." It is based in Research Triangle Park, NC.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.